RPG Life Sciences, a company in the Pharmaceuticals industry, reported revenue of ₹212 crore and net profit of ₹28 crore for the September 2026 quarter.
RPG Life Sciences (NSE: RPGLIFE) closed at ₹2,540.90 on 20 Nov 2026, up 14.2% over the past year. Its market capitalisation is ₹4,202 crore and it trades at 36.6 times earnings.
Incorporated in 2007, RPG Life Sciences Ltd manufactures and markets Formulations (Finished Dosage Forms) and Active Pharma Ingredients
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.